Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritis

Koduri, Gouri M. and Mukhtyar, Chetan ORCID: https://orcid.org/0000-0002-9771-6667 (2019) Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritis. Rheumatology, 58 (4). pp. 559-560. ISSN 1462-0324

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	LivePure Connector
Date Deposited:	27 Nov 2019 01:59
Last Modified:	18 Jun 2026 18:21
URI:	https://ueaeprints.uea.ac.uk/id/eprint/73089
DOI:	10.1093/rheumatology/key097

Actions (login required)

View Item